GC WellBeing Corporation (KOSDAQ:234690)
South Korea · Delayed Price · Currency is KRW 10,750
+1,520 (16.47%)
At close: Sep 3, 2026
GC WellBeing Market Cap
GC WellBeing has a market cap or net worth of 185.67 billion as of September 4, 2026. Its market cap has increased by 15.74% in one year.
Market Cap
185.67B
Enterprise Value
271.46B
Revenue
192.21B
Ranking
n/a
PE Ratio
38.52
Stock Price
10,750.00
ChartMarket Cap Chart
Since October 14, 2019, GC WellBeing's market cap has decreased from 221.90B to 185.67B, a decrease of -16.33%. That is a compound annual growth rate of -2.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 185.67B | 14.47% |
| Dec 30, 2025 | 162.19B | -9.18% |
| Dec 30, 2024 | 178.59B | 23.74% |
| Dec 28, 2023 | 144.33B | -1.22% |
| Dec 29, 2022 | 146.10B | -18.92% |
| Dec 30, 2021 | 180.19B | -27.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 279.71B |
| ImmuneOncia Therapeutics | 263.97B |
| DAE HWA Pharmaceutical | 201.91B |
| Vivozon Pharmaceutical | 186.51B |
| NOVAREX | 180.11B |
| Cosmax Nbt | 176.36B |
| CellBion | 164.54B |
| Kyung Dong Pharmaceutical | 149.72B |